| CRISPR Medicine | This is an overview of our news stories
Japanese researchers have developed a screening system using diphtheria toxin resistance to identify CRISPR-Cas9 variants with enhanced...
Regeneron Pharmaceuticals and Tessera Therapeutics have formed a global partnership to develop and commercialise TSRA-196, Tessera’s lead in vivo Gene...
Some of the best links we picked up around the internet
Personalized gene-editing treatments remain out of reach for most patients in Europe today. To understand why, it helps to look at the front lines. At...
Minutes ago, French and Italian researchers published a gene-editing strategy using adenine base editors to precisely repair two of the most common...
Researchers have identified FZD6 as a promising therapeutic target for advanced prostate cancer through systematic screening of Wnt receptors,...
The CRISPRMED26 Conference in Copenhagen, April 2026, is fast becoming the leading global forum for CRISPR and genomic medicine, and a premier...
